Benefit with enfortumab vedotin confirmed
Nat Rev Clin Oncol
.
2021 May;18(5):258.
doi: 10.1038/s41571-021-00493-1.
Author
Diana Romero
1
Affiliation
1
Nature Reviews Clinical Oncology, . nrclinonc@nature.com.
PMID:
33649567
DOI:
10.1038/s41571-021-00493-1
No abstract available
Publication types
Comment
MeSH terms
Antibodies, Monoclonal* / therapeutic use
B7-H1 Antigen*
Humans
Substances
Antibodies, Monoclonal
B7-H1 Antigen
enfortumab vedotin